XML 17 R15.htm IDEA: XBRL DOCUMENT
v3.19.3

CONCENTRATIONS | 9 Months Ended
--- | ---
Sep. 30, 2019
CONCENTRATIONS |
CONCENTRATIONS | (9) CONCENTRATIONS For the three months ended September 30, 2019, the Company sourced approximately 49% of the supplies for its electrotherapy products from two significant vendors (defined as supplying at least 10%). For the same period in 2018, the Company sourced approximately 51% of the supplies from three significant vendors. For the nine months ended September 30, 2019, the Company sourced approximately 49% of supplies for its electrotherapy products from one significant vendor. For the same period in 2018 the company sourced approximately 44% of supplies from one significant vendor. Management believes that its relationships with suppliers are good. However, if the relationships were to be replaced, there may be a short-term disruption to operations, a period of time in which products may not be available and additional expenses may be incurred. The Company had receivables from two health insurance carriers at September 30, 2019 that made up approximately 38% of the net accounts receivable balance. The Company had receivables from one health insurance carrier at December 31, 2018, that made up approximately 23%, respectively, of the net accounts receivable balance.

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -URI http://asc.fasb.org/topic&trid=2134479 + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration